Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, announced its financial and operational results for the fourth quarter and fiscal year 2026 ending March 31, 2026.
Record Annual Financial Performance
The company achieved record annual global medical cannabis net revenue of $288.6 million, representing an 18% year-over-year increase. Additionally, Aurora delivered a record annual Adjusted EBITDA of $53.8 million, reflecting a 32% year-over-year growth. These results underscore the strength of Aurora's global medical cannabis strategy.
Strategic Acquisition and Balance Sheet Strength
In April 2026, Aurora completed the accretive acquisition of Safari Flower Company, an established EU-GMP manufacturer. This acquisition adds critical capacity to serve growing profitable international markets. The company maintains a strong balance sheet with approximately $164.7 million in cash, short-term investments, and cash equivalents, with no debt.
Fourth Quarter 2026 Highlights
Total net revenue for the fourth quarter was $84.8 million, compared to $76.8 million in the prior year period, a 10% increase. This growth was primarily driven by a 14% increase in global medical cannabis business and higher wholesale bulk cannabis net revenue, partially offset by lower quarterly net revenue in the consumer cannabis business.
Executive Chairman and CEO Miguel Martin stated: “During fiscal year 2026, we exceeded our projection for global medical cannabis net revenue led by double-digit growth in Europe and delivered on our expectation for Adjusted EBITDA, with both at record outcomes. Our performance validates Aurora’s global medical cannabis strategy which has positioned us as a leading provider in Canada, Europe, Australia, and New Zealand.”
Martin added: “We believe Aurora’s leadership in medical cannabis is built upon our regulatory expertise, extensive and recently expanded supply network of EU-GMP certified facilities, and proven commercial execution. We are confident that these attributes create a competitive advantage as we navigate the evolving industry dynamics to maintain and expand global market share, while driving international growth.”
All financial figures are in Canadian dollars and reflect continuing operations unless otherwise noted. On February 17, 2026, the company completed the divestiture of its 50.1% ownership interest in Bevo Agtech Inc., which has been excluded from Q4 2026 continuing results as a discontinued operation.
